• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Achilles Therapeutics plc - American Depositary Shares (NQ:ACHL)

1.480 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.480
Bid (Size) 1.470 (1)
Ask (Size) 1.480 (560)
Prev. Close 1.480
Today's Range 1.480 - 1.480
52wk Range 0.9220 - 1.510
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks have an unusual volume in today's session
February 11, 2025
Unusual volume stocks in Tuesday's session 
Via Chartmill
On Thursday, there are stocks with unusual volume. Let's take a look.
February 06, 2025
Let's explore the current happenings on the US markets on Thursday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill

Performance

YTD
+29.8%
+29.8%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+49.5%
+49.5%

More News

Read More
These stocks have an unusual volume in today's session
February 05, 2025
Via Chartmill
Discover the top movers in Tuesday's pre-market session.
February 04, 2025
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 04, 2025
Via Benzinga
Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts
December 24, 2024
Via Benzinga
Achilles Therapeutics Shares Are Trading Higher: What You Need To Know
September 19, 2024
Via Benzinga
ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024
August 14, 2024
Via InvestorPlace
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
May 22, 2024
From Achilles Therapeutics PLC
Via GlobeNewswire
ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024
May 08, 2024
Via InvestorPlace
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 08, 2024
From Achilles Therapeutics PLC
Via GlobeNewswire
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
April 04, 2024
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Thursday's Intraday Session
April 04, 2024
Via Benzinga
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
April 04, 2024
Via Benzinga
Topics Stocks
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Via Benzinga
ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023
April 04, 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 04, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 04, 2024
Via InvestorPlace
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
April 04, 2024
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
April 04, 2024
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
February 05, 2024
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
December 18, 2023
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
November 13, 2023
From Achilles Therapeutics PLC
Via GlobeNewswire
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
October 23, 2023
Via ACCESSWIRE
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
Via Investor Brand Network

Frequently Asked Questions

Is Achilles Therapeutics plc - American Depositary Shares publicly traded?
Yes, Achilles Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Achilles Therapeutics plc - American Depositary Shares trade on?
Achilles Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Achilles Therapeutics plc - American Depositary Shares?
The ticker symbol for Achilles Therapeutics plc - American Depositary Shares is ACHL on the Nasdaq Stock Market
What is the current price of Achilles Therapeutics plc - American Depositary Shares?
The current price of Achilles Therapeutics plc - American Depositary Shares is 1.480
When was Achilles Therapeutics plc - American Depositary Shares last traded?
The last trade of Achilles Therapeutics plc - American Depositary Shares was at 03/20/25 04:00 PM ET
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap